Menu Close

Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model

Charles 0 Comments
Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model

ALS is a devastating neurodegenerative illness with few healing methods. Each sporadic and familial ALS show frequent medical options that present progressive paralysis. The pathogenesis stays unclear, however disruption of the blood-spinal wire barrier (BSCB) could contribute to the degeneration of motor neurons. Thus, restoration of the disrupted BSCB and neuroprotection for degenerating motor neurons may very well be therapeutic targets. We examined the speculation that an intravenous infusion of MSCs would delay illness development by means of the preservation of BSCB perform and elevated expression of a neurotrophic issue, neurturin, in SOD1G93AALS rats. When the open-field locomotor perform was underneath 16 on the Basso, Beattie, and Bresnahan (BBB) scoring scale, the rats had been randomized into two teams; one acquired an intravenous infusion of MSCs, whereas the opposite acquired automobile alone. Locomotor perform was recorded utilizing BBB scoring and rotarod testing.

Histological analyses, quantitative reverse transcription-polymerase chain response (qRT-PCR), had been carried out. The MSC group exhibited decreased deterioration of locomotor exercise in comparison with the automobile group, which displayed progressive deterioration of hind limb perform. We noticed the safety of motor neuron loss and preservation of microvasculature utilizing Evans blue leakage and immunohistochemical analyses within the MSC group. Confocal microscopy revealed infused inexperienced fluorescent protein+ (GFP+) MSCs within the spinal wire, and the GFP gene was detected by nested PCR. Neurturin expression ranges had been considerably increased within the MSC group. Thus, restoration of the BSCB and the safety of motor neurons is likely to be contributing mechanisms to delay illness development in SOD1G93AALS rats.

Single-molecule stage structural dynamics of DNA unwinding by human mitochondrial Twinkle helicase

Data of the molecular occasions in mitochondrial DNA (mtDNA) replication is essential to understanding the origins of human issues arising from mitochondrial dysfunction. Twinkle helicase is an integral part of mtDNA replication. Right here, we employed atomic drive microscopy imaging in air and liquids to visualise ring meeting, DNA binding, and unwinding exercise of particular person Twinkle hexamers on the single-molecule stage. We noticed that the Twinkle subunits self-assemble into hexamers and higher-order complexes that may change between open and closed-ring configurations within the absence of DNA. Our analyses helped visualize Twinkle loading onto and unloading from DNA in an open-ringed configuration. In addition they revealed that closed-ring conformers bind and unwind a number of hundred base pairs of duplex DNA at a mean price of ∼240 bp/min.
We discovered that the addition of mitochondrial single-stranded (ss) DNA-binding protein each influences the methods Twinkle hundreds onto outlined DNA substrates and stabilizes the unwound ssDNA product, leading to a ∼5-fold stimulation of the obvious DNA-unwinding price. Mitochondrial ssDNA-binding protein additionally elevated the estimated translocation processivity from 1750 to >9000 bp earlier than helicase disassociation, suggesting that greater than half of the mitochondrial genome may very well be unwound by Twinkle throughout a single DNA-binding occasion. The methods used on this work present a brand new platform to look at Twinkle illness variants and the core mtDNA replication equipment. In addition they provide an enhanced framework to research molecular mechanisms underlying deletion and depletion of the mitochondrial genome as noticed in mitochondrial ailments.
The epidermal tissues of the cuticular membrane (CM) and periderm membrane (PM) confer first-line safety from environmental stresses in terrestrial vegetation. Though PM safety is actually ubiquitous in vegetation, the protecting mechanism, the perform of many transcription components and enzymes, and the genetic management of metabolic signaling pathways are poorly understood. Totally different microphenotypes and mobile elements in russet (PM-covered) and inexperienced (CM-covered) fruit skins of pear had been revealed by scanning and transmission electron microscopy. The 2 sorts of fruit skins confirmed distinct phytohormone accumulation, and totally different transcriptomic and proteomic profiles. The enriched pathways had been detected by differentially expressed genes and proteins from the 2 omics analyses.
Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model

TNF-α-Inhibition Improves the Biocompatibility of Porous Polyethylene Implants In Vivo

To enhance the biocompatibility of porous polyethylene (PPE) implants and broaden their software vary for reconstructive surgical procedure in poorly vascularized environments, implants had been coated with tumor necrosis issue α (TNFα) inhibitor Etanercept. Whereas accredited for systemic software, native software of the drug is a novel experimental method. Microvascular and mechanical integration in addition to parameters of irritation had been analyzed in vivo.
PPE implants had been coated with Etanercept and extracellular matrix (ECM) elements previous to implantation into dorsal skinfold chambers of C57BL/6 mice. Fluorescence microscopy analyses of angiogenesis and native inflammatory response had been thrice carried out in vivo over a interval of 14 days to evaluate tissue integration and biocompatibility. Uncoated implants and ECM-coated implants served as controls.
TNFα inhibition with Etanercept led to a decreased native inflammatory response: leukocyte-endothelial cell adherence was considerably lowered in comparison with each management teams (n = 6/group) on days three and 14, the place the bottom values had been reached: 3573.88 leukocytes/mm-2 ± 880.16 (uncoated implants) vs. 3939.09 mm-2 ± 623.34 (Matrigel solely) vs. 637.98 mm-2 + 176.85 (Matrigel and Etanercept). Implant-coating with Matrigel alone and Matrigel and Etanercept led to considerably increased vessel densities 7 and 14 days vs. three days after implantation and in comparison with uncoated implants. Mechanical implant integration as measured by dynamic breaking energy didn’t differ after 14 days.

Toluidine Blue (C.I. 50240)
GT7960-25G 25 g
EUR 84

Toluidine Blue (C.I. 50240)
GT7960-5G 5 g
EUR 55.2

5-Nitro-o-toluidine
S-3862 1ML
EUR 71.82

4‐NITRO‐O‐TOLUIDINE
914004 each Ask for price

OPTIONAL BLUE FILTER (497NM)
GDBL-BLUE 1/pk
EUR 1298.4
Description: Lab Equipment; Axygen Branded EQ

conversion screen uv/blue
VLFC26-BLUE ea
EUR 727.2

N,N-Diethyl-o-toluidine
20-abx185990
  • EUR 661.20
  • EUR 326.40
  • 250 g
  • 50 g

o-Toluidine 1000ug/mL in MeOH
REAZO033 1ML
EUR 95.76

o-Toluidine 2000ug/mL in MeOH
REAZO034 1ML
EUR 120.84

2-O-Benzyl-3-O-allyl-sn-glycerol
O-1005.0001 1.0g
EUR 270
Description: Sum Formula: C13H18O3; CAS# [106401-57-4]

2-O-Benzyl-3-O-allyl-sn-glycerol
O-1005.0005 5.0g
EUR 963.6
Description: Sum Formula: C13H18O3; CAS# [106401-57-4]

1-O-Hexadecyl-2-O-methyl-sn-glycerol
O-1245.0250 250.0mg
EUR 181.2
Description: Sum Formula: C20H42O3; CAS# [96960-92-8]

1-O-Hexadecyl-2-O-methyl-sn-glycerol
O-1245.1000 1.0g
EUR 471.6
Description: Sum Formula: C20H42O3; CAS# [96960-92-8]

1-O-Hexadecyl-2-O-methyl-rac-glycerol
O-1350.0250 250.0mg
EUR 181.2
Description: Sum Formula: C20H42O3; CAS# [84337-41-7]

1-O-Hexadecyl-2-O-methyl-rac-glycerol
O-1350.1000 1.0g
EUR 471.6
Description: Sum Formula: C20H42O3; CAS# [84337-41-7]

1-O-Octadecyl-2-O-benzyl-sn-glycerol
O-1360.0001 1.0g
EUR 151.2
Description: Sum Formula: C28H50O3; CAS# [80707-93-3]

1-O-Octadecyl-2-O-benzyl-sn-glycerol
O-1360.0005 5.0g
EUR 501.6
Description: Sum Formula: C28H50O3; CAS# [80707-93-3]

3-O-Hexadecyl-2-O-acetyl-sn-glycero-1-phosphocholine
O-1255.0005 5.0mg
EUR 400.8
Description: Sum Formula: C26H54NO7P; CAS# [117985-57-6]

3-O-Hexadecyl-2-O-acetyl-sn-glycero-1-phosphocholine
O-1255.0025 25.0mg
EUR 1488
Description: Sum Formula: C26H54NO7P; CAS# [117985-57-6]

1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
O-1270.0025 25.0mg
EUR 254.4
Description: Sum Formula: C26H54NO7P; CAS# [74389-68-7]

1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
O-1270.0100 100.0mg
EUR 618
Description: Sum Formula: C26H54NO7P; CAS# [74389-68-7]

1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
O-1270.0500 500.0mg
EUR 2212.8
Description: Sum Formula: C26H54NO7P; CAS# [74389-68-7]

1-O-Octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
O-1355.0025 25.0mg
EUR 254.4
Description: Sum Formula: C28H58NO7P; CAS# [74389-69-8]

1-O-Octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
O-1355.0100 100.0mg
EUR 618
Description: Sum Formula: C28H58NO7P; CAS# [74389-69-8]

1-O-Octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
O-1355.0500 500.0mg
EUR 2212.8
Description: Sum Formula: C28H58NO7P; CAS# [74389-69-8]

1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphocholine
O-1385.0025 25.0mg
EUR 327.6
Description: Sum Formula: C27H58NO6P; CAS# [77286-66-9]

1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphocholine
O-1385.0100 100.0mg
EUR 907.2
Description: Sum Formula: C27H58NO6P; CAS# [77286-66-9]

1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine
O-1415.0025 25.0mg
EUR 270
Description: Sum Formula: C27H58NO6P; CAS# [70641-51-9]

1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine
O-1415.0100 100.0mg
EUR 734.4
Description: Sum Formula: C27H58NO6P; CAS# [70641-51-9]

5-Nitro-o-toluidine 1000ug/mL in MeOH
REAZO021 1ML
EUR 139.08

5-Nitro-o-toluidine 2000ug/mL in MeOH
REAZO022 1ML
EUR 193.8

1-O-(cis-9-Octadecenyl)-2-O-acetyl-sn-glycero-3-phosphocholine
O-1030.0050 50.0mg
EUR 471.6
Description: Sum Formula: C28H56NO7P; CAS# [85966-90-1]

1-O-(cis-9-Octadecenyl)-2-O-acetyl-sn-glycero-3-phosphocholine
O-1030.0250 250.0mg
EUR 1778.4
Description: Sum Formula: C28H56NO7P; CAS# [85966-90-1]

3-O-Allyl-sn-glycerol
O-1000.0001 1.0g
EUR 151.2
Description: Sum Formula: C6H12O3; CAS# [55941-86-1]

3-O-Allyl-sn-glycerol
O-1000.0005 5.0g
EUR 501.6
Description: Sum Formula: C6H12O3; CAS# [55941-86-1]

1-O-Benzyl-sn-glycerol
O-1010.0001 1.0g
EUR 327.6
Description: Sum Formula: C10H14O3; CAS# [17325-85-8]

1-O-Benzyl-sn-glycerol
O-1010.0005 5.0g
EUR 1197.6
Description: Sum Formula: C10H14O3; CAS# [17325-85-8]

3-O-Benzyl-sn-glycerol
O-1015.0001 1.0g
EUR 254.4
Description: Sum Formula: C10H14O3; CAS# [56552-80-8]

3-O-Benzyl-sn-glycerol
O-1015.0005 5.0g
EUR 907.2
Description: Sum Formula: C10H14O3; CAS# [56552-80-8]

1,2-O-Dihexadecyl-sn-glycerol
O-1040.0001 1.0g
EUR 211.2
Description: Sum Formula: C35H72O3; CAS# [67337-03-5]

1,2-O-Dihexadecyl-sn-glycerol
O-1040.0005 5.0g
EUR 733.2
Description: Sum Formula: C35H72O3; CAS# [67337-03-5]

1,2-O-Dihexadecyl-rac-glycerol
O-1045.0001 1.0g
EUR 211.2
Description: Sum Formula: C35H72O3; CAS# [13071-60-8]

1,2-O-Dihexadecyl-rac-glycerol
O-1045.0005 5.0g
EUR 733.2
Description: Sum Formula: C35H72O3; CAS# [13071-60-8]

1,2-O-Dioctadecyl-sn-glycerol
O-1155.0001 1.0g
EUR 327.6
Description: Sum Formula: C39H80O3; CAS# [82188-61-2]

1,2-O-Dioctadecyl-sn-glycerol
O-1155.0005 5.0g
EUR 1197.6
Description: Sum Formula: C39H80O3; CAS# [82188-61-2]

1,2-O-Dioctadecyl-rac-glycerol
O-1160.0001 1.0g
EUR 211.2
Description: Sum Formula: C39H80O3; CAS# [6076-38-6]

1,2-O-Dioctadecyl-rac-glycerol
O-1160.0005 5.0g
EUR 733.2
Description: Sum Formula: C39H80O3; CAS# [6076-38-6]

1-O-Hexadecyl-sn-glycerol
O-1285.0001 1.0g
EUR 270
Description: Sum Formula: C19H40O3; CAS# [506-03-6]

1-O-Hexadecyl-sn-glycerol
O-1285.0005 5.0g
EUR 907.2
Description: Sum Formula: C19H40O3; CAS# [506-03-6]

1-O-Hexadecyl-rac-glycerol
O-1290.0001 1.0g
EUR 151.2
Description: Sum Formula: C19H40O3; CAS# [6145-69-3]

1-O-Hexadecyl-rac-glycerol
O-1290.0005 5.0g
EUR 501.6
Description: Sum Formula: C19H40O3; CAS# [6145-69-3]

3-O-Hexadecyl-sn-glycerol
O-1295.0001 1.0g
EUR 211.2
Description: Sum Formula: C19H40O3; CAS# [10550-58-0]

3-O-Hexadecyl-sn-glycerol
O-1295.0005 5.0g
EUR 733.2
Description: Sum Formula: C19H40O3; CAS# [10550-58-0]

1-O-Octadecyl-sn-glycerol
O-1365.0001 1.0g
EUR 270
Description: Sum Formula: C21H44O3; CAS# [6129-13-1]

1-O-Octadecyl-sn-glycerol
O-1365.0005 5.0g
EUR 907.2
Description: Sum Formula: C21H44O3; CAS# [6129-13-1]

1-O-Octadecyl-rac-glycerol
O-1370.0005 5.0g
EUR 181.2
Description: Sum Formula: C21H44O3; CAS# [544-62-7]

1-O-Octadecyl-rac-glycerol
O-1370.0025 25.0g
EUR 618
Description: Sum Formula: C21H44O3; CAS# [544-62-7]

p-Toluidine
20-abx185551
  • EUR 226.80
  • EUR 326.40
  • EUR 276.00
  • 100 g
  • 1 kg
  • 500 g

m-Toluidine
S-3515 1ML
EUR 69.54

p-Toluidine
S-3525 1ML
EUR 90.06

P‐TOLUIDINE
920006 each Ask for price

1,2-O-Dihexadecyl-sn-glycero-3-phosphocholine
O-1050.0250 250.0mg
EUR 181.2
Description: Sum Formula: C40H84NO6P; CAS# [36314-47-3]

1,2-O-Dihexadecyl-sn-glycero-3-phosphocholine
O-1050.1000 1.0g
EUR 471.6
Description: Sum Formula: C40H84NO6P; CAS# [36314-47-3]

1-O-Hexadecyl-sn-glycero-3-phosphocholine
O-1300.0025 25.0mg
EUR 254.4
Description: Sum Formula: C24H52NO6P; CAS# [52691-62-0]

1-O-Hexadecyl-sn-glycero-3-phosphocholine
O-1300.0100 100.0mg
EUR 618
Description: Sum Formula: C24H52NO6P; CAS# [52691-62-0]

1-O-Octadecyl-sn-glycero-3-phosphocholine
O-1380.0025 25.0mg
EUR 254.4
Description: Sum Formula: C26H56NO6P; CAS# [74430-89-0]

1-O-Octadecyl-sn-glycero-3-phosphocholine
O-1380.0100 100.0mg
EUR 618
Description: Sum Formula: C26H56NO6P; CAS# [74430-89-0]

1,2-O-Dihexadecyl-sn-glycero-3-phosphoethanolamine
O-1435.0250 250.0mg
EUR 254.4
Description: Sum Formula: C37H78NO6P; CAS# [61423-61-8]

1,2-O-Dihexadecyl-sn-glycero-3-phosphoethanolamine
O-1435.1000 1.0g
EUR 691.2
Description: Sum Formula: C37H78NO6P; CAS# [61423-61-8]

Rack for haemolysis tubes o 20 mm blue colour
DD391083 EACH
EUR 13.68

Fluorescence Microscopy Aid
4400 3 ml
EUR 216.6
Description: This is Counter - Stain/Blocking Diluent with optimal formula for preparaiton of final dilutions of FITC conjugate prior to use in FA procedures.

BCIP toluidine salt
BB0072 500mg
EUR 161.27

1-O-(cis-9-Octadecenyl)-sn-glycero-3-phosphocholine
O-1035.0050 50.0mg
EUR 400.8
Description: Sum Formula: C26H54NO6P; CAS# [97802-55-6]

1-O-(cis-9-Octadecenyl)-sn-glycero-3-phosphocholine
O-1035.0250 250.0mg
EUR 1488
Description: Sum Formula: C26H54NO6P; CAS# [97802-55-6]

1-O-Hexadecyl-2-desoxy-2-amino-sn-glycerol
O-1520.0025 25.0mg
EUR 151.2
Description: Sum Formula: C19H41NO2; CAS# [136770-76-8]

1-O-Hexadecyl-2-desoxy-2-amino-sn-glycerol
O-1520.0100 100.0mg
EUR 385.2
Description: Sum Formula: C19H41NO2; CAS# [136770-76-8]

1-O-Hexadecyl-2-desoxy-2-amino-sn-glycerol
O-1520.0500 500.0mg
EUR 1341.6
Description: Sum Formula: C19H41NO2; CAS# [136770-76-8]

Round label for tube cap o 13 mm blue colour
DD53067 EACH
EUR 57.23

Round label for tube cap o 9.5 mm blue colour
DD53137 PK3840
EUR 135.66

SCREW CAPS WITH "O" RINGS. BLUE
SCO-B 500/pk
EUR 444
Description: Micro Tubes; Screw-Cap Microtubes - Axygen

EZClick? O-GalNAc Modified Glycoprotein Assay Kit (FACS/Microscopy, Green Fluorescence)
K560-100 each
EUR 588

EZClick? O-GlcNAc Modified Glycoprotein Assay Kit (FACS/Microscopy, Green Fluorescence)
K714-100 each
EUR 614.4

BCIP p-Toluidine Salt
abx082537-100mg 100 mg
EUR 243.6

Round label for tube cap o 9.5 mm colour : blue orange
DD53139 PK3840
EUR 135.66

LOOPED SCREW CAPS WITH "O" RINGS. BLUE
SCO-LP-B 500/pk
EUR 451.2
Description: Micro Tubes; Screw-Cap Microtubes - Axygen

Screw Cap w O-ring - Light Blue
TUB1098 PK3000
EUR 121.98

BCIP, toluidine (5-bromo-4-chloro-3-indoxyl phosphate, p-toluidine salt): (100mg)
10002 100MG
EUR 136.8
Description: Minimum order quantity: 1 unit of 100MG

BCIP, toluidine (5-bromo-4-chloro-3-indoxyl phosphate, p-toluidine salt): (500mg)
10002-1 500MG
EUR 345.6
Description: Minimum order quantity: 1 unit of 500MG

BCIP, toluidine (5-bromo-4-chloro-3-indoxyl phosphate, p-toluidine salt): (5g)
10002-2 5G
EUR 1489.2
Description: Minimum order quantity: 1 unit of 5G

ORANGE LOOPED SCREW CAPS WITH "O" RINGS. FITS 0.5ML, 1.5ML AND 2.0ML TUBES
SCO-LP-O 500/pk
EUR 451.2
Description: Micro Tubes; Screw-Cap Microtubes - Axygen

Blue Base for Dissecting Board
M625 1 ea.
EUR 240

Rack Blue For 30Mm Tubes
5972-0330 EACH
EUR 21.66

Blue metal tags for cryocanes
ARG1572 PK12
EUR 38.3

Cap Insert for Cryotube Blue
390470 PK1000
EUR 21.5

Rack for 100x1.5ml Microtubes Blue
CEN9382 EACH
EUR 19.38

O' in 1 DNA Polymerase Premix 2xwi Blue Dye
FYT206-100P 100 Preps 1.25ml x 2 vials Ask for price

safePort? O-ring cap, HP, BLUE, sterile, 500 pcs/pk
502B-11pk each
EUR 115.2

safePort? O-ring cap, LP, BLUE, sterile, 500 pcs/pk
505B-11pk each
EUR 115.2

Monoclonal antibody for O-GlcNAc
SMC-502D 0.1mg
EUR 506.4
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is not conjugated.

Monoclonal antibody for O-GlcNAc
SMC-502D-A390 0.1mg
EUR 562.8
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with ATTO 390.

Monoclonal antibody for O-GlcNAc
SMC-502D-A488 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with ATTO 488.

Monoclonal antibody for O-GlcNAc
SMC-502D-A565 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with ATTO 565.

Monoclonal antibody for O-GlcNAc
SMC-502D-A594 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with ATTO 594.

Monoclonal antibody for O-GlcNAc
SMC-502D-A633 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with ATTO 633.

Monoclonal antibody for O-GlcNAc
SMC-502D-A655 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with ATTO 655.

Monoclonal antibody for O-GlcNAc
SMC-502D-A680 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with ATTO 680.

Monoclonal antibody for O-GlcNAc
SMC-502D-A700 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with ATTO 700.

Monoclonal antibody for O-GlcNAc
SMC-502D-ALP 0.1mg
EUR 554.4
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with Alkaline Phosphatase.

Monoclonal antibody for O-GlcNAc
SMC-502D-APC 0.1mg
EUR 560.4
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with APC.

Monoclonal antibody for O-GlcNAc
SMC-502D-APCCY7 0.1mg
EUR 648
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with APC/Cy7.

Monoclonal antibody for O-GlcNAc
SMC-502D-BI 0.1mg
EUR 556.8
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with Biotin.

Monoclonal antibody for O-GlcNAc
SMC-502D-DY350 0.1mg
EUR 579.6
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with Dylight 350.

Monoclonal antibody for O-GlcNAc
SMC-502D-DY405 0.1mg
EUR 565.2
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with Dylight 405.

Monoclonal antibody for O-GlcNAc
SMC-502D-DY488 0.1mg
EUR 553.2
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with Dylight 488.

Monoclonal antibody for O-GlcNAc
SMC-502D-DY594 0.1mg
EUR 555.6
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with Dylight 594.

Monoclonal antibody for O-GlcNAc
SMC-502D-DY633 0.1mg
EUR 549.6
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with Dylight 633.

Monoclonal antibody for O-GlcNAc
SMC-502D-FITC 0.1mg
EUR 552
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with FITC.

Monoclonal antibody for O-GlcNAc
SMC-502D-HRP 0.1mg
EUR 548.4
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with HRP.

Monoclonal antibody for O-GlcNAc
SMC-502D-P594 0.1mg
EUR 570
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with PE/ATTO 594.

Monoclonal antibody for O-GlcNAc
SMC-502D-PCP 0.1mg
EUR 560.4
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with PerCP.

Monoclonal antibody for O-GlcNAc
SMC-502D-RPE 0.1mg
EUR 558
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with RPE.

Monoclonal antibody for O-GlcNAc
SMC-502D-STR 0.1mg
EUR 559.2
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is conjugated with Streptavidin.

Monoclonal antibody for O-GlcNAc
SMC-502S 0.012mg
EUR 78
Description: A monoclonal antibody from clone 9H6 against Human O-GlcNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GlcNAc is not conjugated.

Monoclonal antibody for O-GalNAc
SMC-503D 0.1mg
EUR 506.4
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is not conjugated.

Monoclonal antibody for O-GalNAc
SMC-503D-A390 0.1mg
EUR 562.8
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with ATTO 390.

Monoclonal antibody for O-GalNAc
SMC-503D-A488 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with ATTO 488.

Monoclonal antibody for O-GalNAc
SMC-503D-A565 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with ATTO 565.

Monoclonal antibody for O-GalNAc
SMC-503D-A594 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with ATTO 594.

Monoclonal antibody for O-GalNAc
SMC-503D-A633 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with ATTO 633.

Monoclonal antibody for O-GalNAc
SMC-503D-A655 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with ATTO 655.

Monoclonal antibody for O-GalNAc
SMC-503D-A680 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with ATTO 680.

Monoclonal antibody for O-GalNAc
SMC-503D-A700 0.1mg
EUR 561.6
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with ATTO 700.

Monoclonal antibody for O-GalNAc
SMC-503D-ALP 0.1mg
EUR 554.4
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with Alkaline Phosphatase.

Monoclonal antibody for O-GalNAc
SMC-503D-APC 0.1mg
EUR 560.4
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with APC.

Monoclonal antibody for O-GalNAc
SMC-503D-APCCY7 0.1mg
EUR 648
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with APC/Cy7.

Monoclonal antibody for O-GalNAc
SMC-503D-BI 0.1mg
EUR 556.8
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with Biotin.

Monoclonal antibody for O-GalNAc
SMC-503D-DY350 0.1mg
EUR 579.6
Description: A monoclonal antibody from clone 9B9 against Human O-GalNAc. The host species for the production of this antibody is Mouse. The antigen used for immunization is Synthetic ?-O-Linked N-Acetylglucosamine conjugated to Keyhole Limpet Hemocyanin (KLH).. The antibody is tested and validated for WB, ICC/IF, IHC, ELISA assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:50); ELISA (1:1000); IHC (1:25). This MAb for O-GalNAc is conjugated with Dylight 350.
Our knowledge present a decreased native inflammatory response to PPE implants after immunomodulatory coating with Etanercept in vivo, suggesting improved biocompatibility. Software of this tissue engineering method is subsequently warranted in fashions of a compromised host setting.
Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *